Update on acquisition of Primerdesign Ltd

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, updates the market on its intended acquisition of Primerdesign Ltd (“Primerdesign”), a profitable and rapidly growing UK molecular diagnostics company. Download press release

Visit Page

Novacyt announces initiation of coverage by Invest Securities

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that Invest Securities, an independent investment banking and advisory group, based in Paris, has initiated research coverage of Novacyt. Download press release

Visit Page

Novacyt Announces Proposed Acquisition of Primer Design Ltd

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has entered into a definitive agreement to acquire the entire share capital of Primer Design Ltd, a profitable and rapidly growing UK molecular diagnostics company. Download press release

Visit Page